Yahoo India Web Search

  1. Ad

    related to: dr reddy's laboratories ltd
  2. Easily Find Medication At Affordable Prices. Amazon Offers an Array Of Unique Products From Hundreds Of Brands.

Search results

  1. Dr. Reddys is a global pharmaceutical company with a purpose of ‘Good Health Can’t Wait’. It offers products and services across API, generics, branded generics, biosimilars and over-the-counter pharmaceutical products in over 100 countries.

  2. Dr. Reddy's Laboratories is an Indian multinational pharmaceutical company based in Hyderabad. The company was founded by Kallam Anji Reddy, who previously worked in the mentor institute Indian Drugs and Pharmaceuticals Limited. [2] . Dr. Reddy manufactures and markets a wide range of pharmaceuticals in India and overseas.

  3. Learn about Dr. Reddys Laboratories, a trusted name in the Indian healthcare industry since 1986. Explore its portfolio of over 200 products across therapy areas, its robust field force and inventory management system, and its Purple Health initiative to address patient needs.

  4. Learn about Dr. Reddy's Laboratories, a global pharmaceutical company based in Hyderabad, India. See their products, services, markets, sustainability goals, and latest updates on LinkedIn.

  5. Dr. Reddy's Laboratories Limited Stock Price Today, Live NSE Share Price: Get the latest Dr. Reddy's Laboratories Limited news, company updates, quotes, tips, historical charts, 52 week high low, market performance financial reports and many more at NSE India.

  6. 15 hours ago · Shares of Dr Reddy's Labs have surged about 3 per cent to Rs 6417.95 during the trading session on Friday, commanding a total market capitalization of close to Rs 1.10 lakh crore.

  7. People also ask

  8. 2 days ago · Dr Reddy’s Laboratories Ltd on Wednesday said it has signed a definitive agreement with Haleon plc, a leading consumer healthcare company, for purchase of shares of its group company Northstar Switzerland SARL, to acquire a global portfolio of consumer healthcare brands outside of the United States for a total consideration of GBP 500 million.